.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Zydus Lifesciences recently announced the launch of AI glucose monitors in India. These next-generation Continuous Glucose Monitoring (CGM) devices, Diasens and GlucoLive, aim to transform modern diabetes management. By integrating artificial intelligence, Zydus provides a more connected care ecosystem for patients and clinicians alike. Consequently, this technology bridge improves real-time clinical decision-making.
The new CGM systems stream glucose readings to smartphones every three minutes. Furthermore, this ensures an uninterrupted capture of data, even during the night or in emergencies. The integrated AI layer identifies trends and flags hypoglycemic or hyperglycemic episodes immediately. Additionally, the system links these fluctuations to specific food intake and physical activities. Therefore, clinicians can offer more precise, personalized advice to their patients based on comprehensive glycaemic data. Moreover, the automatic streaming eliminates the need for manual logging by the patient.
The technology functions through the TatvaCare GoodFlip application. This app generates actionable insights from complex data sets. Because the app shares data in real-time, caregivers and doctors can intervene more quickly. Such advancements simplify the monitoring process for those living with chronic conditions. Moreover, the closed-loop ecosystem ensures that no critical reading goes unnoticed. This launch strengthens the companion diagnostics portfolio for Zydus in the Indian market.
Q1: How often do the Diasens and GlucoLive devices update glucose readings?
The devices automatically stream glucose readings to the patient’s smartphone every three minutes, ensuring continuous and real-time monitoring.
Q2: What is the primary role of the AI layer in these CGM devices?
The AI layer analyzes data trends to flag hypo- and hyperglycaemic episodes while linking fluctuations to the patient's diet and activity levels.
Q3: Which app is used to view the data from these Zydus AI glucose monitors?
Patients use the TatvaCare GoodFlip app, which provides AI-driven analytics and connects them with clinicians and caregivers.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Zydus Lifesciences introduces AI-powered Diasens and GlucoLive CGM devices in India for real-time glucose tracking and advanced diabetes management insights...
5 months ago
A large NHANES cohort study reveals that higher Healthy Eating Index scores significantly reduce all-cause mortality risk in CKD patients by 45%. This analysis highlights the importance of comprehensive diet quality and medical nutrition therapy in renal care to optimize long-term clinical survival.
Today
A prospective cohort study demonstrates that poor adolescent sleep quality, especially long sleep latency and reduced efficiency, increases dysmenorrhea severity in young adulthood. Addressing adolescent rest patterns offers a critical preventive avenue for clinicians.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Today
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
